MDO and Insurer Questions About AI in Clinics

AI use may become relevant during insurer renewal, PMI due diligence, an MDO query, a complaint or a clinical incident. The organisation may be asked practical questions: what tool was used, who approved it, whether the clinician reviewed the output, whether the patient was informed and what governance process existed. ELSA AI does not provide insurer coverage advice or MDO indemnity advice. We help providers organise the evidence likely to be relevant to those discussions.

Who this is for

  • Clinic owners and boards
  • GP partners
  • Practice managers
  • Clinicians using AI-assisted documentation
  • Governance leads preparing renewal or disclosure materials

Questions that may arise

Checklist

  • Which AI tools are used in documentation, transcription, triage or clinical workflows?
  • Does patient data enter the tool?
  • Who approved the tool?
  • Was a DPIA completed or reviewed?
  • Is vendor evidence available?
  • Are clinicians required to review AI-generated outputs?
  • Are patients informed where AI records, transcribes or supports documentation?
  • Does the incident process cover AI-related errors?
  • Has material AI use been reviewed with advisers where relevant?

Common evidence gaps

Checklist

  • AI use not recorded
  • Scribe live without central evidence file
  • No human-review protocol
  • No patient transparency wording
  • No AI incident route
  • No disclosure-readiness note
  • No board-adopted AI position

Careful wording: use

  • may affect indemnity support
  • should be clarified directly with the MDO or insurer
  • disclosure-readiness evidence
  • final decision remains with provider

Avoid

  • cover void
  • claim will be rejected
  • insurer will not pay
  • MDO will refuse support

What ELSA AI can help produce

The Diagnostic includes disclosure-readiness indicators aligned to common renewal and incident questions.

Outputs include

  • Board Findings Report
  • RAG Exposure Map
  • AI Tool and Use Case Inventory
  • DPIA Readiness and Patient Data Exposure Note
  • Vendor Data Position and Evidence Tracker
  • Ambient Scribe Assessment Sheet, where applicable
  • MDO, PMI and Insurer Disclosure Readiness Note
  • 30-Day Priority Action Plan
  • Source and Guidance Mapping Appendix

Advisory governance support only. Not legal advice, DPIA sign-off, CQC approval, ICO approval, insurer coverage advice, MDO indemnity advice or clinical safety case sign-off. Final decisions remain with the organisation's accountable officers and advisers.

Need this evidence mapped for your clinic or group?

The Clinical AI Exposure Diagnostic™ gives clinic leadership a board-ready view of AI use, patient-data exposure, evidence gaps and priority actions in four working days from the start of delivery.

Book a Free Governance CallView Diagnostic deliverables

Related guides